Diffuse low-grade glioma: a review on the new molecular classification, natural history and current management strategies.
about
Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma.Impact of concurrent versus adjuvant chemotherapy on the severity and duration of lymphopenia in glioma patients treated with radiation therapy.The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis.Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors.Genetic and Epigenetic Features of Rapidly Progressing IDH-Mutant Astrocytomas
P2860
Diffuse low-grade glioma: a review on the new molecular classification, natural history and current management strategies.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Diffuse low-grade glioma: a re ...... current management strategies.
@en
Diffuse low-grade glioma: a re ...... current management strategies.
@nl
type
label
Diffuse low-grade glioma: a re ...... current management strategies.
@en
Diffuse low-grade glioma: a re ...... current management strategies.
@nl
prefLabel
Diffuse low-grade glioma: a re ...... current management strategies.
@en
Diffuse low-grade glioma: a re ...... current management strategies.
@nl
P2093
P2860
P1476
Diffuse low-grade glioma: a re ...... current management strategies.
@en
P2093
E Lastra-Aras
E M Corrales-García
M T Dueñas-Polo
P2860
P2888
P304
P356
10.1007/S12094-017-1631-4
P577
2017-03-02T00:00:00Z